Telehealth startup Cerebral will stop prescribing Adderall for new ADHD patients The company says it will continue to prescribe controlled substances for other conditions. Axios · May 4, 2022
Field Trip And Cerebral Partner To Bring Together Teletherapy, Telepsychiatry, And Psychedelic-Assisted Therapy Field Trip Health Ltd. (NASDAQ:FTRP) (TSX:FTRP) and Cerebral are launching a partnership where Cerebral clinicians can refer qualified clients to Field Trip Health's ketamine assisted therapy, while Field Trip will connect potential clients seeking general psychiatry and teletherapy services to Cerebral. This end-to-end solution will provide personalized treatment solutions for… Benzinga · Mar 3, 2022